🧬 MULTIPLE SCLEROSIS PROFILE
Estrogen is neuroprotective. Many women with MS report clearer cognition and lower fatigue in the follicular phase — and the reverse as estrogen falls late-luteal. This pattern is documented in the literature and almost entirely ignored by supplement brands.
Selene's MS protocol combines the strongest evidence-based neuroprotective nutrients with cycle-phase timing — front-loading remyelination support when estrogen is rising and protective, weighting anti-fatigue compounds in the luteal window when symptoms peak.
Not on any hormonal contraception · Protocol adjusts to your natural cycle
THE MECHANISM
“Premenstrual worsening of neurological symptoms was reported by 70% of women with MS, correlating with the late-luteal drop in estrogen and progesterone.”
Bove & Chitnis, Multiple Sclerosis Journal (2014) — survey of 149 women with confirmed MS diagnosis
Estrogen is neuroprotective
Estrogen receptors are expressed throughout the CNS. Rising estrogen in the follicular phase promotes remyelination signals and suppresses pro-inflammatory cytokines — one reason pregnancy (high estrogen) is associated with MS remission.
Late luteal = highest risk
When estrogen and progesterone fall in the days before menstruation, inflammatory activity rises and neuroprotective signaling weakens. 70% of women with MS report this as their highest-symptom window.
Vitamin D is the strongest lever
Of all dietary factors studied in MS, vitamin D has the most consistent evidence. Low serum D predicts higher relapse rate. Latitude correlates with MS prevalence globally. The MS protocol uses 5000 IU — double a general immune dose.
THE MS PROTOCOL
The core stack runs daily. Three ingredients — magnesium, CoQ10, melatonin — adjust dose or timing based on where you are in your cycle, weighted toward the luteal window when symptom burden peaks.
The most evidence-backed nutritional intervention in MS. Latitude correlates with MS prevalence globally. Low vitamin D predicts relapse rate. 5000 IU targets serum levels associated with reduced inflammatory activity — roughly double what a general immune protocol uses.
Human trials in secondary progressive MS show significant reduction in brain atrophy rate. A potent neuroprotective antioxidant that crosses the blood-brain barrier, reduces oxidative stress in CNS tissue, and regenerates vitamins C and E.
At doses 3,000x the RDA, biotin acts as a cofactor in fatty acid synthesis and energy metabolism in neurons — supporting remyelination rather than just general B-vitamin function. Studied specifically in progressive MS. Note: interferes with some lab tests (thyroid, troponin). Pause 48h before bloodwork.
DHA is a structural component of myelin sheaths. Higher DHA intake correlates with lower brain atrophy in MS cohorts. EPA reduces the neuroinflammatory cytokine cascade. This is myelin maintenance, not general anti-inflammation.
B12 (methylcobalamin) is required for myelin synthesis — deficiency is directly demyelinating. Methylated forms bypass MTHFR variants, which are more common in autoimmune conditions. B1 (thiamine) has pilot data for MS fatigue at high dose.
Addresses spasticity, muscle cramping, and neurological fatigue — the most common MS symptoms that worsen pre-menstrually. Glycinate form maximizes CNS delivery. Dose increases in the luteal phase when both magnesium demand and symptom burden typically peak.
MS fatigue is neurological lassitude — mitochondrial failure in axons, not metabolic tiredness. CoQ10 ubiquinol supports mitochondrial function in CNS tissue. Prioritized in the luteal phase when neurological fatigue typically worsens as estrogen falls.
MS disrupts circadian rhythm, and melatonin modulates the Th1/Th2 immune balance in ways specific to autoimmune demyelination. Low-dose (1mg) supports immune rhythm and sleep architecture without suppressing the natural melatonin surge. Added in the luteal window when sleep disruption and immune activation are highest.
High-dose biotin interferes with lab assays for thyroid and cardiac markers. Pause 48h before bloodwork. Share the full stack with your neurologist before starting.
WHAT CHANGES EACH PHASE
Estrogen rising is neuroprotective. Many women with MS report sharper cognition and lower fatigue in this window. Core stack runs: D3, ALA, biotin, omega-3, B-complex.
Estrogen peaks. Peak neuroprotective window. Some women report a brief symptom dip immediately post-ovulation as estrogen falls sharply before the luteal rise.
Progesterone dominant. Estrogen falls late-luteal. The window where MS symptoms most commonly worsen. CoQ10 and magnesium dose increases. Melatonin added for immune rhythm and sleep.
Estrogen and progesterone both falling. Highest symptom risk window for many women with MS. Full stack active. Fatigue, spasticity, and cognitive fog are most likely here — the stack is weighted for this.
Oura Ring integration — coming soon
HRV dips are a documented early signal of MS fatigue episodes — often appearing 24–48 hours before subjective fatigue is felt. Once connected, your Oura data will inform daily stack adjustments: lower HRV triggers higher CoQ10 and magnesium prioritization. We'll notify founding members first when the integration goes live.
COMMON QUESTIONS
FOUNDING MEMBERS
$39/mo Essential or $69/mo Full Protocol — price locked forever. Founding members get Oura integration first and direct input on which condition profiles we build next.